Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 30 results.
User Information
Export Records
  1. 1.   Inhibition of HIV-1 release by ADAM metalloproteinase inhibitors
  2. Ireland, Joanna; Segura, Jason; Shi,Genbin; Buchwald, Julianna; Roth, Gwynne; Shen, Thomas Juncheng; Wang, Ruipeng; Ji,Xinhua; Fischer, Elizabeth R; Moir, Susan; Chun, Tae-Wook; Sun, Peter D
  3. Frontiers in Microbiology. 2024, Mar 20; 15: 1385775.
  1. 2.   Structural analyses of the Haemophilus influenzae peptidoglycan synthase activator LpoA suggest multiple conformations in solution
  2. Sathiyamoorthy, Karthik; Vijayalakshmi, J; Tirupati, Bhramara; Fan, Lixin; Saper, Mark A
  3. The Journal of Biological Chemistry. 2017, Oct 27; 292(43): 17626-17642.
  1. 3.   An overview of enzymatic reagents for the removal of affinity tags
  2. Waugh, D. S.
  3. Protein Expression and Purification. 2011, Dec; 80(2): 283-293.
  1. 4.   Rapid Cancer Detection by Topically Spraying a gamma-Glutamyltranspeptidase-Activated Fluorescent Probe
  2. Urano, Y.; Sakabe, M.; Kosaka, N.; Ogawa, M.; Mitsunaga, M.; Asanuma, D.; Kamiya, M.; Young, M. R.; Nagano, T.; Choyke, P. L.; Kobayashi, H.
  3. Science Translational Medicine. 2011, Nov; 3(110): 10.
  1. 5.   The substrate specificity of Metarhizium anisopliae and Bos taurus carboxypeptidases A: Insights into their use as tools for the removal of affinity tags
  2. Austin, B. P.; Tozser, J.; Bagossi, P.; Tropea, J. E.; Waugh, D. S.
  3. Protein Expression and Purification. 2011, May; 77(1): 53-61.
  1. 6.   Developmental Cardiac Hypertrophy in a Mouse Model of Prolidase Deficiency
  2. Jung, S.; Silvius, D.; Nolan, K. A.; Borchert, G. L.; Millet, Y. H.; Phang, J. M.; Gunn, T. M.
  3. Birth Defects Research Part a-Clinical and Molecular Teratology. 2011, Apr; 91(4): 204-217.
  1. 7.   A Remote Arene-Binding Site on Prostate Specific Membrane Antigen Revealed by Antibody-Recruiting Small Molecules
  2. Zhang, A. X.; Murelli, R. P.; Barinka, C.; Michel, J.; Cocleaza, A.; Jorgensen, W. L.; Lubkowski, J.; Spiegel, D. A.
  3. Journal of the American Chemical Society. 2010, Sep; 132(36): 12711-12716.
  1. 8.   Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure-activity relationship studies
  2. Wang, H. F.; Byun, Y.; Barinka, C.; Pullambhatla, M.; Bhang, H. E. C.; Fox, J. J.; Lubkowski, J.; Mease, R. C.; Pomper, M. G.
  3. Bioorganic & Medicinal Chemistry Letters. 2010, Jan; 20(1): 392-397.
  1. 9.   Structural insight into the evolutionary and pharmacologic homology of glutamate carboxypeptidases II and III
  2. Hlouchova, K.; Barinka, C.; Konvalinka, J.; Lubkowski, J.
  3. Febs Journal. 2009 276(16): 4448-4462.
  1. 10.   Reaction Mechanism of Glutamate Carboxypeptidase II Revealed by Mutagenesis, X-ray Crystallography, and Computational Methods
  2. Klusak, V.; Barinka, C.; Plechanovova, A.; Mlcochova, P.; Konvalinka, J.; Rulisek, L.; Lubkowski, J.
  3. Biochemistry. 2009 48(19): 4126-4138.
  1. 11.   Interactions between Human Glutamate Carboxypeptidase II and Urea-Based Inhibitors: Structural Characterization
  2. Barinka, C.; Byun, Y.; Dusich, C. L.; Banerjee, S. R.; Chen, Y.; Castanares, M.; Kozikowski, A. P.; Mease, R. C.; Pomper, M. G.; Lubkowski, J.
  3. Journal of Medicinal Chemistry. 2008 51(24): 7737-7743.
  1. 12.   Use of a recombinant fluorescent substrate with cleavage sites for all botulinum neurotoxins in high-throughput screening of natural product extracts for inhibitors of serotypes A, B, and E
  2. Hines, H. B.; Kim, A. D.; Stafford, R. G.; Badie, S. S.; Brueggeman, E. E.; Newman, D. J.; Schmidt, J. J.
  3. Applied and Environmental Microbiology. 2008 74(3): 653-659.
  1. 13.   Metastasis-associated gene expression profile of liver and subcutaneous lesions derived from mouse pheochromocytoma cells
  2. Ohta, S.; Lai, E. W.; Morris, J. C.; Pang, A.; Watanabe, M.; Yazawa, H.; Zhang, R.; Green, J. E.; Chan, W. Y.; Sirajuddin, P.; Taniguchi, S.; Powers, J. F.; Tischler, A. S.; Pacak, K.
  3. Molecular Carcinogenesis. 2008 47(4): 245-251.
  1. 14.   Structural insight into the pharmacophore pocket of human glutamate carboxypeptidase II
  2. Barinka, C.; Rovenska, M.; Mlcochova, P.; Hlouchova, K.; Plechanovova, A.; Majer, P.; Tsukamoto, T.; Slusher, B. S.; Konvalinka, J.; Lubkowski, J.
  3. Journal of Medicinal Chemistry. 2007, Jul; 50(14): 3267-3273.
  1. 15.   A refined pharmacophore identifies potent 4-amino-7-chloroquinoline-based inhibitors of the botulinum neurotoxin serotype a metalloprotease
  2. Burnett, J. C.; Opsenica, D.; Sriraghavan, K.; Panchal, R. G.; Ruthel, G.; Hermone, A. R.; Nguyen, T. L.; Kenny, T. A.; Lane, D. J.; McGrath, C. F.; Schmidt, J. J.; Vennerstrom, J. L.; Gussio, R.; Solaja, B. A.; Bavari, S.
  3. Journal of Medicinal Chemistry. 2007, May; 50(9): 2127-2136.
  1. 16.   A high-resolution structure of ligand-free human glutamate carboxypeptidase II
  2. Barinka, C.; Starkova, J.; Konvalinka, J.; Lubkowski, J.
  3. Acta Crystallographica Section F-Structural Biology and Crystallization Communications. 2007, Mar; 63: 150-153.
  1. 17.   Inhibition of metalloprotease botulinum serotype A from a pseudo-peptide binding mode to a small molecule that is active in primary neurons
  2. Burnett, J. C.; Ruthel, G.; Stegmann, C. M.; Panchal, R. G.; Nguyen, T. L.; Hermone, A. R.; Stafford, R. G.; Lane, D. J.; Kenny, T. A.; McGrath, C. F.; Wipf, P.; Stahl, A. M.; Schmidt, J. J.; Gussio, R.; Brunger, A. T.; Bavari, S.
  3. Journal of Biological Chemistry. 2007, Feb; 282(7): 5004-5014.
  1. 18.   Proteomic analysis of plasma membrane from hypoxia-adapted malignant melanoma
  2. Stockwin, L. H.; Blonder, J.; Bumke, M. A.; Lucas, D. A.; Chan, K. C.; Conrads, T. P.; Issaq, H. J.; Veenstra, T. D.; Newton, D. L.; Rybak, S. M.
  3. Journal of Proteome Research. 2006, Nov; 5(11): 2996-3007.
  1. 19.   Processing, catalytic activity and crystal structures of kumamolisin-As with an engineered active site
  2. Okubo, A.; Li, M.; Ashida, M.; Oyama, H.; Gustchina, A.; Oda, K.; Dunn, B. M.; Wlodawer, A.; Nakayama, T.
  3. Febs Journal. 2006, Jun; 273(11): 2563-2576.
  1. 20.   The importance of dynamics in substrate-assisted catalysis and specificity
  2. Xu, Q.; Guo, H.; Wlodawer, A.; Guo, H.
  3. Journal of the American Chemical Society. 2006, MAY 10; 128(18): 5994-5995.
  1. 21.   The catalytic domain of Escherichia coli Lon protease has a unique fold and a Ser-Lys dyad in the active site
  2. Botos, I.; Melnikov, E. E.; Cherry, S.; Tropea, J. E.; Khalatova, A. G.; Rasulova, F.; Dauter, Z.; Maurizi, M. R.; Rotanova, T. V.; Wlodawer, A.; Gustchina, A.
  3. Journal of Biological Chemistry. 2004 279(9): 8140-8148.
  1. 22.   Completely automated, highly error-tolerant macromolecular structure determination from multidimensional nuclear overhauser enhancement spectra and chemical shift assignments
  2. Kuszewski, J.; Schwieters, C. D.; Garrett, D. S.; Byrd, R. A.; Tjandra, N.; Clore, G. M.
  3. Journal of the American Chemical Society. 2004 126(20): 6258-6273.
  1. 23.   A model of the ACE2 structure and function as a SARS-CoV receptor
  2. Prabakaran, P.; Mao, X. D.; Dimitrov, D. S.
  3. Biochemical and Biophysical Research Communications. 2004 314(1): 235-241.
  1. 24.   Cancer-specific ligands identified from screening of peptide-display libraries
  2. Mori, T.
  3. Current Pharmaceutical Design. 2004 10(19): 2335-2343.
  1. 25.   Unlocking the secrets of cytotoxic granule proteins
  2. Smyth, M. J.; Kelly, J. M.; Sutton, V. R.; Davis, J. E.; Browne, K. A.; Sayers, T. J.; Trapani, J. A.
  3. Journal of Leukocyte Biology. 2001 70(1): 18-29.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel